Locate Therapeutics Ltd is rated 3 out of 5 in the category biotechnology. Read and write reviews about Locate Therapeutics Ltd. Locate Therapeutics was a regenerative medicine development company active between 2014-2018 and is now known as Locate Bio Ltd. Lead asset TAOS® (Targeted Orchestrated Signalling matrix) is a patented polymer technology with multiple medical applications. Locate has a number of in-house development programmes focussed on improving treatment in high-value orthopaedic applications. The company is also developing complementary enabling technologies for regenerative medicine commercialization, including innovations for cell therapy bioprocessing and gene delivery.
Company size
11-50 employees
Headquarters
Nottingham, England